The Food and Drug Administration claims that Glaxo Wellcome's Spanish-language television advertisements for Flonase® (fluticasone) nasal spray, which ran in Puerto Rico in 1998 and 1999, failed to disclose risk information.
The Food and Drug Administration claims that Glaxo Wellcome's Spanish-language television advertisements for Flonase® (fluticasone) nasal spray, which ran in Puerto Rico in 1998 and 1999, failed to disclose risk information.
In an August 18 warning letter to the company, the FDA said the ads failed "to provide information relating to the major side effects and contraindications" and failed to make "adequate provision for the dissemination of the approved labeling, or inclusion of the brief summary of information related to the side effects and contraindication in conjunction with the advertisement."
The FDA letter continued: "In fact, the advertisement mentions only the indication for Flonase (relief of nasal allergy symptoms) and provides no risk information at all."
In addition, Glaxo Wellcome failed to submit the ads to the FDA, which requires such submissions at the time of the advertisement's first use.
Glaxo Wellcome has discontinued the ads, but the FDA is requiring that the company "assure FDA that similar advertisements are not being disseminated anywhere in the United States or its territories and possessions." PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.